Perspective Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.10.24	Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report (Benzinga)
05.09.24	Perspective Therapeutics: FDA Grants Fast Track Designation For Development Of 212Pb VMT01 (RTTNews)
11.06.24	Perspective Therapeutics Announces Reverse Stock Split - Quick Facts (RTTNews)
19.03.24	Perspective Therapeutics Inks Clinical Trial Collaboration Agreement With Bristol Myers (RTTNews)
29.01.24	Perspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying (Benzinga)
18.01.24	Why Perspective Therapeutics (CATX) Shares Are Falling (Benzinga)
05.01.24	Perspective Enters Patent License Agreement For PSMA Alpha-PET DoubLET Platform Technology (RTTNews)
19.12.23	Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying (Benzinga)
14.03.23	Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care (PR Newswire)
28.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TALO, ISR, FCRD, SESN (PR Newswire)
30.09.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OCSL, SESN, ISR (PR Newswire)
27.09.22	Ausblick: IsoRay präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
07.02.22	Ausblick: IsoRay gewährt Anlegern Blick in die Bücher (finanzen.net)
25.10.21	Pre-market Movers: MARK, SONM, CRTD, INPX, COMS… (RTTNews)
19.09.21	Ausblick: IsoRay präsentiert Quartalsergebnisse (finanzen.net)
11.05.21	Ausblick: IsoRay mit Zahlen zum abgelaufenen Quartal (finanzen.net)
07.02.21	Ausblick: IsoRay gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
07.01.21	Pre-market Movers In Healthcare Sector: GHSI, NMTR, NXTD, ADXN, DBVT… (RTTNews)
06.01.21	Pre-market Movers In Healthcare Sector: ISR, GHSI, NMTR, CHEK, BBI… (RTTNews)
08.11.20	Ausblick: IsoRay präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
20.10.20	Pre-market Movers In Healthcare Sector: ACOR, APTX, CARA, CBLI, IVA, ISR… (RTTNews)
16.09.20	Ausblick: IsoRay veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
11.05.20	Ausblick: IsoRay zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
10.02.20	Ausblick: IsoRay informiert über die jüngsten Quartalsergebnisse (finanzen.net)
07.05.19	Ausblick: IsoRay legt Zahlen zum jüngsten Quartal vor (finanzen.net)
10.02.19	Ausblick: IsoRay verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
06.11.18	Ausblick: IsoRay zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
10.07.18	ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN (RTTNews)
06.02.18	Danaos Corporation Announces Date for the Release of Fourth Quarter 2017 Results, Conference Call and Webcast (PR Newswire)
02.11.17	Global A&T Electronics Ltd. Reaches Comprehensive Restructuring Agreement with All Stakeholders (PR Newswire)
28.09.17	IsoRay Announces Fourth Quarter Fiscal 2017 Revenue of $1.37 Million, 22% Fourth Quarter-over-Fourth Quarter Increase (PR Newswire)
26.09.17	IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy (PIB): (PR Newswire)
25.09.17	IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American... (PR Newswire)
31.08.17	IsoRay Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017 (PR Newswire)
04.08.17	IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase (PR Newswire)
01.08.17	New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients (PR Newswire)
07.07.17	IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer (PR Newswire)
06.07.17	IsoRay Receives FDA Response to 510(k) Application for GammaTile™ (PR Newswire)
20.06.17	IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and... (PR Newswire)
10.05.17	IsoRay Announces Third Quarter Fiscal 2017 Financial Results (PR Newswire)
03.05.17	IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with... (PR Newswire)
07.02.17	MicroCap Review Magazine Winter/Spring 2017 Issue Now Available (PR Newswire)
11.01.17	Purcell Julie & Lefkowitz LLP Is Investigating IsoRay, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
22.12.16	IsoRay Medical, Inc. Discusses Cesium-131 and its Applications in New SNNLive Video Interview on StockNewsNow.com (PR Newswire)
21.12.16	IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Resectable High Risk Recurrent Head and Neck Cancer by Case... (PR Newswire)
30.11.16	IsoRay to Present at 9th Annual LD Micro Investor Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Perspective Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten